Gladiolin Candida albicans research shows a bacterial molecule can disarm an invasive fungal form and boost antifungal drugs.

Invasive C. auris infections have been associated with mortality rates of 30 percent to 60 percent among hospitalized ...

Intravenous SCY-247 was generally well tolerated in healthy participants, with no drug-related serious adverse eventsOnce-daily intravenous doses ...

High-dose budesonide reduced esophageal stricture formation and the need for dilation after extensive ESD, although questions ...

Cell-free postbiotic mediators derived from two well-known probiotic strains suppressed the metabolic activity of Candida albicans biofilms, with LGG-derived preparations showing the stronger ...

FDA grants bioMérieux dual clearance and CLIA waiver for the BIOFIRE SPOTFIRE Vaginitis Panel, a rapid 20-minute ...

(NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases, announces that SCY-247, its second-generation ...

I applied it before going out, but it's itchy again. I can't scratch in public, so I reapply it in a bathroom stall.When I ...

Shionogi will present SENTRY Surveillance Program data evaluating cefiderocol against 1,400 global P. aeruginosa isolates collected from patients with VAP in the U.S. and Europe between 2020-2024. 2P.

("Orogen" or the "Company") today announced the selection of two development candidates (DCs), ORO-110 and ORO-210, potential best-in-class oral small molecule inhibitors of IL-17 and JAK1/TYK2, ...

A six-year retrospective cohort study at a Palestinian tertiary hospital found that half of 36 patients with ...

Learn the warning signs of oesophagitis and the potential complications of leaving it untreated ...